Faster Launch, Increased Adoption, Higher Revenue, and a Playbook for Commercial Success. Read the white paper.
Download Now
Skip to content
prognos-logo-light Prognos Health
Main Menu
  • Support
  • Client Login
  • Request Demo
  • Prognos Factor®
    • Marketplace
      • Explore & Buy Data
      • Become a Data Provider
  • Products
    • Life Sciences
      • Cohort Designer
      • Patient Journey Software
      • Physician Segmentation
      • Outcomes Insights
      • Alerts
      • Omnichannel Marketing
    • Payers
      • Underwriting Risk Predictor
  • Company
    • Careers
    • News
    • Insights
    • Resources
  • Contact Us
Home Insights 3 Steps to Faster Patient Journey Mapping for Pharma Brand Success

3 Steps to Faster Patient Journey Mapping for Pharma Brand Success

  • November 19, 2021
  • Posted in Patient Journey
patient journey mapping

Understanding the longitudinal patient journey — from symptoms to testing, to diagnosis and treatment — is a standard and essential part of any life science company’s business practice. 

To optimally position your therapy in the market, you need insight into the following questions:

  • How does the disease progress that our therapy is designed to treat? 
  • How and when do doctors identify the disease and with what tests? 
  • How do providers land on a treatment decision?

Answering these key questions can take a considerable amount of time and resources using traditional methods. Multiple data sources must be contracted and managed while significant manual effort is required to ensure disparate data sets are harmonized, standardized, and compliant. All this must be completed before any analysis can be applied or insights derived. 

Accelerating your ability to visualize and assess via patient journey mapping can give you a substantial edge over competitors.

Map the patient journey faster and more accurately in 3 steps:

1. Start with harmonized lab data

Gaining the best insight into how disease progression and severity impacts treatment decisions requires analysis of lab test results over time. While many in the life science industry understand the business value of this information, few have been able to unlock it to inform decisions at scale.

The reason?

Lab data is messy. Variability in lab data types, schemas, and formats is common and synching this information manually is often impossible, so scant insight is gleaned from raw data purchased directly from a variety of sources. 

Prognos FactorⓇ healthcare data and analytics software does the heavy lifting for you. The platform consolidates de-identified data from multiple lab sources (as well as medical and prescription claims sources) in a single location — harmonizing the data and making it compliant in the process. Once normalized, lab data can be quickly analyzed and linked to other data, providing answers to key clinical questions in minutes instead of months.

2. Enable quick multipoint analysis 

Completely visualizing the longitudinal patient journey requires analysis of multiple patient and provider characteristics, patterns, and trends. For example, you’ll want to study when, where, and how treatment decisions are made, including the influence of lab testing and provider touchpoints, as well as what channels and messaging are most timely and impactful.

Prognos Factor provides built-in analytics tools that enable you to quickly:

  • Perform patient and physician segmentation and targeting
  • Determine market size, patient populations, and market opportunity
  • Establish look-back periods for newly diagnosed or treated patients, grace periods for continuing therapy, and look-forward/overlap periods for building regimens
  • Discern how treatment decisions vary by patient characteristics 
  • Determine how often patients interact with different providers
  • Pinpoint how often patients are seen, tested, and treated
  • Track medication persistence and compliance
  • Understand treatment paths and lines of therapy

Prognos Factor supports the complete commercial lifecycle.

3. Set the stage for rapid iteration

Patient journey analysis doesn’t have to be one and done. It can be an ongoing process that enables you to keep tabs on the most up-to-date patient and provider data to track the impact of existing strategies and pivot to maximize Rx lift.

Prognos Factor continually refreshes its repository with new incoming data and custom alerts can be sent to you when new data matching your patient profiles are available in the system. Plus, since the platform is cloud-based, you can perform additional analysis on data sets as often and as quickly as your brand strategy demands. 

Map and act on the longitudinal patient journey more quickly and accurately with Prognos Factor. 

Schedule a customized demo of our patient journey mapping tool with one of our clinical experts today.

« Highlights from The Data Ecosystem in 2025
Prevent drug launch failure with an end-to-end RWD solution »

Categories

  • AI
  • Alerts
  • Clinical
  • Commercial Launch Excellence
  • Disease Awareness
  • Lab Testing Insights
  • Lab Testing Trends
  • Marketplace
  • Omnichannel Marketing
  • Patient Journey
  • Physician Segmentation
  • Prog Spotlight
  • RWD
  • Technology
  • Underwriting

Archives

Latest Tweets

Prognos HealthFollow

Query billions of fully-integrated lab & health records on more than 325M de-identified patients to answer key healthcare questions in minutes on prognosFACTOR.

Prognos Health
prognosAIPrognos Health@prognosAI·
12 Apr

In our recent panel discussion “How to determine your next best action for every HCP engagement”, leaders from Novartis, GSK, and Takeda Oncology discussed their #RWD strategies to commercialize drug therapies. 3 important best practices were revealed. https://prognoshealth.com/blog/provider-engagement/?utm_source=twitter&utm_medium=social&utm_campaign=provider_engagement_blog

Reply on Twitter 1513876896056057856Retweet on Twitter 1513876896056057856Like on Twitter 1513876896056057856Twitter 1513876896056057856
prognosAIPrognos Health@prognosAI·
7 Apr

68% of #pharma leaders believe the way #lifescience companies currently purchase patient-level data is ripe for disruption.

Find out what challenges dominate current #RWD efforts and how technology can help address them.

https://prognoshealth.com/blog/real-world-data-pharma-paradigm-shift/?utm_source=twitter&utm_medium=social&utm_campaign=rwd_paradigm_shift_blog

#RealWorldData

Reply on Twitter 1512114401360461827Retweet on Twitter 15121144013604618271Like on Twitter 1512114401360461827Twitter 1512114401360461827
prognosAIPrognos Health@prognosAI·
5 Apr

Therapy-related #RWD insights and learnings for a new brand launch can take 12-18 months. One leading #pharma company cut this time in half. Find out how.
https://prognoshealth.com/resource/rwd-analysis/?utm_source=twitter&utm_medium=social&utm_campaign=oncology_case_study

#Omnichannel #Oncology #Pharmaceutical #TherapyLaunch #RealWorldData

Reply on Twitter 1511355425660325897Retweet on Twitter 15113554256603258971Like on Twitter 15113554256603258971Twitter 1511355425660325897
prognosAIPrognos Health@prognosAI·
3 Mar

In a recent survey of #pharma leaders by Reuters, 68% of respondents believe the way #LifeSciences companies currently purchase patient-level data is ripe for disruption.

Find out what challenges dominate current #RWD efforts and how technology can help.

https://prognoshealth.com/blog/real-world-data-pharma-paradigm-shift/?utm_source=twitter&utm_medium=social&utm_campaign=real_world_data_in_pharma_paradigm_shift

Reply on Twitter 1499488030222168066Retweet on Twitter 14994880302221680661Like on Twitter 1499488030222168066Twitter 1499488030222168066
prognosAIPrognos Health@prognosAI·
1 Mar

Dr. Steven Zatz Joins Prognos Health Board of Directors

"Steve’s vision and leadership helped build WebMD into an iconic healthcare brand," says @sundeepbhan1.

https://prognoshealth.com/about-us/news/press-release/dr-steven-zatz-joins-prognos-health-board-of-directors/?utm_source=twitter&utm_medium=social&utm_campaign=dr_zatz_joins_board

Reply on Twitter 1498679196536737795Retweet on Twitter 14986791965367377951Like on Twitter 14986791965367377951Twitter 1498679196536737795
Load More...
  • Prognos Factor®
    • Prognos Marketplace
  • Products
    • Life Sciences
    • Payers
  • Company
    • Insights
    • Careers
    • News
  • LinkedIn
  • Twitter
  • YouTube
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Site Map
© Prognos Health, 2022. All Rights Reserved.

Get Answers Faster

Watch your questions answered with unparalleled speed. De-identified record level patient data already integrated & easily linked to other sources. Prognos puts you in control.

To give you the best possible experience, this site uses cookies and by continuing to use the site you agree that we can save them on your device. For more details about cookies and their use, please see our Privacy Policy.